AMPH
Amphastar P
NASDAQ: AMPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$23.90
+2.18% today
Updated 2026-05-06
Market cap
$974.42M
P/E ratio
10.78
P/S ratio
1.35x
EPS (TTM)
$2.03
Dividend yield
—
52W range
$17 – $31
Volume
0.6M
Amphastar P (AMPH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.10M | $-1.65M | $31.04M | $21.05M | $10.68M | $38.56M | $39.21M | $38.19M | $41.76M | $57.27M | $97.99M | $89.18M | $183.50M | $213.39M | $156.12M |
| Capital expenditures | $10.72M | $25.25M | $18.30M | $20.50M | $16.05M | $21.38M | $35.10M | $46.81M | $41.55M | $33.85M | $27.46M | $24.03M | $38.17M | $41.04M | $34.88M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $8.04M | $7.42M | $7.04M | $9.28M | $12.81M | $15.12M | $17.09M | $16.68M | $17.30M | $20.50M | $18.69M | $17.86M | $20.24M | $24.37M | $27.28M |
| Free cash flow | $8.38M | $-26.89M | $12.74M | $553000.00 | $-5.37M | $17.18M | $4.11M | $-8.62M | $207000.00 | $23.41M | $70.54M | $65.15M | $145.34M | $172.34M | $121.23M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $52.08M | $20.29M | $10.20M | $0.00 | $20.31M | — | $23.16M | $15.93M | $15.66M | $454.09M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $14.24M | $-1.75M | $6.28M | $-6.76M | $20.74M | $-12.55M | $18.61M | $32.30M | $29.96M | — | — | — |